Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Public ClinicalTrials.gov record NCT01836432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study of Chemotherapy With or Without Algenpantucel-L (HyperAcute®-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Study identification
- NCT ID
- NCT01836432
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- NewLink Genetics Corporation
- Industry
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Interventions
- FOLFIRINOX Drug
- Algenpantucel-L Immunotherapy Biological
- 5-FU Chemoradiation Radiation
- Gemcitabine Drug
- Capecitabine Drug
- Nab-Paclitaxel Drug
Drug · Biological · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Jul 28, 2016
- Completion
- Mar 23, 2017
- Last update posted
- May 27, 2020
2013 – 2017
United States locations
- U.S. sites
- 32
- U.S. states
- 23
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85719 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Sutter Institute for Medical Research | Sacramento | California | 95816 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| Stamford Hospital | Stamford | Connecticut | 06902 | — |
| Boca Raton Regional Hospital | Boca Raton | Florida | 33486 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| University of Miami | Miami | Florida | 33136 | — |
| USF Tampa General | Tampa | Florida | 33606 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| Indiana University Health Goshen Center for Cancer Care | Goshen | Indiana | 46526 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| University of Louisville | Louisville | Kentucky | 40292 | — |
| Beaumont CCOP | Royal Oak | Michigan | 48073 | — |
| Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407-3799 | — |
| Renown Regional Medical Center | Reno | Nevada | 89502 | — |
| Jersey Shore University Medical Center | Neptune City | New Jersey | 07753 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22904 | — |
| University of Washington - Seattle Cancer Center Alliance | Seattle | Washington | 98109 | — |
| Vince Lombardi Cancer Center | Green Bay | Wisconsin | 54311 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01836432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2020 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01836432 live on ClinicalTrials.gov.